Evoke Pharma (EVOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,079 | -1,965 | -7,566 | -5,805 | -4,286 |
| Other Working Capital | -200 | -341 | -519 | -652 | -642 |
| Other Operating Activity | 724 | 379 | 1,106 | 728 | 348 |
| Operating Cash Flow | $-3,555 | $-1,927 | $-6,979 | $-5,730 | $-4,580 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,676 | 636 | 4,618 | 4,618 | 3,432 |
| Financing Cash Flow | $5,676 | $636 | $4,618 | $4,618 | $3,432 |
| Beginning Cash Position | 5,319 | 5,319 | 7,679 | 7,679 | 7,679 |
| End Cash Position | 7,440 | 4,029 | 5,319 | 6,568 | 6,531 |
| Net Cash Flow | $2,121 | $-1,291 | $-2,360 | $-1,111 | $-1,148 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,555 | -1,927 | -6,979 | -5,730 | -4,580 |
| Free Cash Flow | -3,555 | -1,927 | -6,979 | -5,730 | -4,580 |